ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 121 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $8,864,000 | -72.6% | 4,640,877 | -33.5% | 0.34% | -68.2% |
| Q2 2015 | $32,404,000 | -19.7% | 6,983,710 | -24.3% | 1.08% | -17.3% |
| Q1 2015 | $40,332,000 | +67.2% | 9,229,379 | +32.7% | 1.31% | +50.6% |
| Q4 2014 | $24,129,000 | -1.5% | 6,953,737 | +18.9% | 0.87% | -2.9% |
| Q3 2014 | $24,503,000 | -4.3% | 5,847,999 | +33.9% | 0.89% | -13.3% |
| Q2 2014 | $25,603,000 | +234.1% | 4,369,066 | +259.1% | 1.03% | +229.1% |
| Q1 2014 | $7,664,000 | +7.7% | 1,216,579 | 0.0% | 0.31% | -15.2% |
| Q4 2013 | $7,117,000 | +11.0% | 1,216,579 | 0.0% | 0.37% | +23.8% |
| Q3 2013 | $6,411,000 | -67.6% | 1,216,579 | -52.6% | 0.30% | -68.0% |
| Q2 2013 | $19,778,000 | – | 2,568,588 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 867,700 | $5,085,000 | 1.68% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,369,066 | $25,603,000 | 1.03% |
| Lyons Wealth Management, LLC. | 56,775 | $334,000 | 0.30% |
| Callan Capital, LLC | 66,118 | $387,000 | 0.10% |
| QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 383,050 | $2,245,000 | 0.06% |
| FCG ADVISORS, LLC | 10,600 | $62,000 | 0.05% |
| OppenheimerFunds, Inc. | 7,000,000 | $41,020,000 | 0.04% |
| NEXT Financial Group, Inc | 19,704 | $86,000 | 0.04% |
| WELLINGTON MANAGEMENT GROUP LLP | 27,893,387 | $163,455,000 | 0.04% |
| MURPHY CAPITAL MANAGEMENT INC | 45,000 | $263,000 | 0.04% |